The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
Kazumasa Komura(Osaka University of Pharmaceutical Sciences), Haruhito Azuma(Osaka Medical and Pharmaceutical University)
Cited by 42
Related Papers
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
|Proceedings of the National Academy of Sciences|1996|167
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.
|Journal of Clinical Investigation|1998|127
Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression
|Clinical Cancer Research|2019|114
A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells
|International Journal of Molecular Sciences|2017|52
Increased <scp> <i>MYBL2</i> </scp> expression in aggressive hormone‐sensitive prostate cancer
|Molecular Oncology|2022|17